ATE311868T1 - Arzneimittel für die rheumatoide arthritis - Google Patents

Arzneimittel für die rheumatoide arthritis

Info

Publication number
ATE311868T1
ATE311868T1 AT00939111T AT00939111T ATE311868T1 AT E311868 T1 ATE311868 T1 AT E311868T1 AT 00939111 T AT00939111 T AT 00939111T AT 00939111 T AT00939111 T AT 00939111T AT E311868 T1 ATE311868 T1 AT E311868T1
Authority
AT
Austria
Prior art keywords
methylene
rheumatoid arthritis
medicinal products
present
lower alkylene
Prior art date
Application number
AT00939111T
Other languages
English (en)
Inventor
Hiroyuki Aono
Miwa Takai
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE311868T1 publication Critical patent/ATE311868T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT00939111T 1999-06-21 2000-06-21 Arzneimittel für die rheumatoide arthritis ATE311868T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP17387599 1999-06-21
PCT/JP2000/004051 WO2000078305A1 (fr) 1999-06-21 2000-06-21 Remedes contre la polyarthrite rhumatoide

Publications (1)

Publication Number Publication Date
ATE311868T1 true ATE311868T1 (de) 2005-12-15

Family

ID=15968757

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00939111T ATE311868T1 (de) 1999-06-21 2000-06-21 Arzneimittel für die rheumatoide arthritis

Country Status (11)

Country Link
US (1) US6576668B1 (de)
EP (1) EP1203583B1 (de)
KR (1) KR100718030B1 (de)
CN (1) CN1184965C (de)
AT (1) ATE311868T1 (de)
AU (1) AU5428300A (de)
CA (1) CA2377686C (de)
DE (1) DE60024636T2 (de)
DK (1) DK1203583T3 (de)
ES (1) ES2254190T3 (de)
WO (1) WO2000078305A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1312149C (zh) * 2002-12-23 2007-04-25 史宝珠 合成Bucillamine的中间体 5,5-二甲基-2-硫酮-4-酮-1-硫-3-氧-杂戊环
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6011888B2 (ja) 1978-10-11 1985-03-28 参天製薬株式会社 リウマチ疾患治療薬
JPS565388A (en) 1979-06-22 1981-01-20 Matsushita Electric Works Ltd Curing method
JPS6011888A (ja) 1983-06-30 1985-01-22 富士通株式会社 漢字パタ−ン記憶方式
JPS6213922A (ja) 1985-07-10 1987-01-22 Kawasaki Steel Corp 冶金用コ−クスの予備処理方法
JPH063263B2 (ja) 1986-07-07 1994-01-12 日本特殊陶業株式会社 ピストンピンとスナツプリングとの潤滑機構
JP2558147B2 (ja) 1988-07-06 1996-11-27 参天製薬株式会社 免疫性疾患治療剤
JP2816499B2 (ja) 1990-10-17 1998-10-27 参天製薬株式会社 糖尿病治療剤
JP2816500B2 (ja) 1990-10-17 1998-10-27 参天製薬株式会社 抗骨粗鬆剤
JP3066608B2 (ja) 1991-01-16 2000-07-17 参天製薬株式会社 腎疾患治療剤
JP2814033B2 (ja) 1992-01-10 1998-10-22 参天製薬株式会社 シスチン尿症治療剤
JP2899740B2 (ja) 1994-02-08 1999-06-02 参天製薬株式会社 炎症性腸疾患治療剤
US6025393A (en) 1995-09-25 2000-02-15 Santen Pharmaceutical Co., Ltd. Method for treatment of inflammatory intestinal diseases
CZ299025B6 (cs) * 1996-02-09 2008-04-02 Amgen Inc. Farmaceutická kompozice a její použití
TW555765B (en) * 1996-07-09 2003-10-01 Amgen Inc Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
JP3569793B2 (ja) 1996-11-29 2004-09-29 参天製薬株式会社 遅延型アレルギー抑制剤
JP3486730B2 (ja) 1997-03-21 2004-01-13 参天製薬株式会社 血管内皮増殖因子阻害剤
JP3496114B2 (ja) 1997-08-29 2004-02-09 参天製薬株式会社 角膜新生血管増殖抑制剤
TW577758B (en) * 1997-10-27 2004-03-01 Ssp Co Ltd Intra-articular preparation for the treatment of arthropathy
EP1082963A4 (de) * 1998-05-20 2004-03-17 Chugai Pharmaceutical Co Ltd Arzneimittel für hyaluronsäure-assozierte gelenkkrankheiten

Also Published As

Publication number Publication date
KR20020009636A (ko) 2002-02-01
DK1203583T3 (da) 2006-04-18
AU5428300A (en) 2001-01-09
EP1203583B1 (de) 2005-12-07
ES2254190T3 (es) 2006-06-16
CN1356898A (zh) 2002-07-03
DE60024636T2 (de) 2006-08-17
CN1184965C (zh) 2005-01-19
EP1203583A4 (de) 2004-03-03
EP1203583A1 (de) 2002-05-08
KR100718030B1 (ko) 2007-05-16
US6576668B1 (en) 2003-06-10
CA2377686A1 (en) 2000-12-28
DE60024636D1 (de) 2006-01-12
WO2000078305A1 (fr) 2000-12-28
CA2377686C (en) 2009-02-03

Similar Documents

Publication Publication Date Title
NZ235323A (en) Amide derivatives and pharmaceutical compositions thereof
ES2057016T3 (es) Compuestos de acido 3-pirrolidiniltio-1-azabiciclo (3.2.0) hept-2-eno-2-carboxilico.
HUT40798A (en) Process for producing new, heterocyclic imidazol derivatives and pharmaceutically acceptable acid additional salts thereof
FI903879A0 (fi) Menetelmä valmistaa farmakologisesti käyttökelpoista tiatsoliyhdistettä
SG15689G (en) Substituted acyl derivatives of 1,2,3,4-tetrahydroiso-quinoline-3-carboxylic acids,salts thereof,pharmaceutical compositions containing the derivatives or salts,and the production of the same
HUT68385A (en) Polypeptide and process for producing thereof
HUT59410A (en) Process for producing 1-methyl carbapenem derivatives and pharmaceutical compositions comprising same as active ingredient
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
DE60032470D1 (de) Heilmittel die sulfopyranosylacylglycerolderivate enthalten
EP0997462A4 (de) Naphthyridinderivate oder salze davon
ATE311868T1 (de) Arzneimittel für die rheumatoide arthritis
IL69881A (en) 1-pyridinyl(or tetrahydropyridinyl)-3-phenyl indenes,their preparation and pharmaceutical compositions comprising them
HUT55349A (en) Process for producing benzanilide derivatives and pharmaceutical compositions comprising same
ES2068497T3 (es) Derivados de urea, su produccion, y composiciones farmaceuticas que los contienen.
FI944040A0 (fi) Laktolijohdannaiset, niiden valmistus ja käyttö
PT89492A (pt) Processo de preparacao de novos derivados de tioformamida terapeuticamente activos
PT1172108E (pt) Utilizacao de derivados de sulfoquinovosildiacilglicerol como imunossupressores
IL136510A0 (en) Acylated hetero-alicyclic derivatives and pharmaceutical compositions containing the same
IL65213A0 (en) Morpholine derivatives,their preparation and pharmaceutical compositions containing them
PT92175A (pt) Processo para a preparacao de 3-amino-sidnoniminas substituidas e de produtos intermediarios farmacologicamente activos
WO1997029078A1 (fr) Derives d'acides d'amides cycliques
EA200100767A1 (ru) Новые производные полигидроксипиразинов, способ их получения и содержащие их фармацевтические композиции
TH14567A (de)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1203583

Country of ref document: EP